From September 15, 2023 to September 30, 2023, the company has repurchased 730,578 shares, representing 0.18% for CNY 25.2 million. With this, the company has completed the repurchase of 730,578 shares, representing 0.18% for CNY 25.2 million under the buyback announced on September 18, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.27 CNY | -2.41% |
|
-3.42% | -25.35% |
20/05 | Wall Street Cues, Central Bank Outlooks Lift Asian Stock Markets | MT |
29/04 | Liaoning Chengda Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.35% | 1.38B | |
+2.99% | 94.76B | |
-3.68% | 37.58B | |
-11.61% | 33.3B | |
+75.73% | 27.92B | |
-13.40% | 15.85B | |
-2.29% | 13.79B | |
-12.21% | 11.51B | |
+188.83% | 10.9B | |
-53.94% | 9.27B |
- Stock Market
- Equities
- 688739 Stock
- News Liaoning Chengda Biotechnology Co.,Ltd.
- Tranche Update on Liaoning Chengda Biotechnology Co.,Ltd.'s Equity Buyback Plan announced on September 18, 2023.